Literature DB >> 26218943

Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review.

Burton D Beakley, Adam M Kaye1, Alan D Kaye.   

Abstract

BACKGROUND: Serotonin syndrome is a mild to potentially life-threatening syndrome associated with excessive serotonergic activity within the central nervous system. Serotonin syndrome is associated with medication use, drug interactions, and overdose. While serotonin syndrome is often associated with the use of selective serotonin inhibitors (SSRI), an increasing number of reports are being presented involving the use of tramadol.
METHODS: This review article contains an overview of serotonin syndrome while specifically looking at tramadol's pharmacology and risk factors for serotonin syndrome. With tramadol's increasing popularity, the goal of this article is to make physicians more alert and aware of this potential side effect associated with tramadol.
CONCLUSIONS: In conclusion, with the increasing incidence of serotonin syndrome, prescribing physicians should be aware of and educate their patients on the potential side effects of tramadol. It is important that the prescribing physician reviews patient medications for concurrent serotonergic drugs and monitors for potential abuse.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26218943

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  53 in total

Review 1.  Tramadol for neuropathic pain in adults.

Authors:  Rudolf Martin Duehmke; Sheena Derry; Philip J Wiffen; Rae F Bell; Dominic Aldington; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-06-15

2.  Acute tramadol enhances brain activity associated with reward anticipation in the nucleus accumbens.

Authors:  Yuki Asari; Yumiko Ikeda; Amane Tateno; Yoshiro Okubo; Takehiko Iijima; Hidenori Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2018-06-27       Impact factor: 4.530

3.  Comment on "Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects".

Authors:  Darías Holgado; Thomas Zandonai; Daniel Sanabria
Journal:  Sports Med       Date:  2019-07       Impact factor: 11.136

4.  [Age 89 years, depression, fall with pelvic fracture, severe confusion - serotonin syndrome : Differential diagnosis, importance of CYP450 and economic considerations].

Authors:  W Weinrebe; A Moutaouakil; K Risz; M Martin; K Jeckelmann; S Goetz
Journal:  Z Gerontol Geriatr       Date:  2017-04-18       Impact factor: 1.281

5.  Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content.

Authors:  Lauren A E Erland; Praveen K Saxena
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

6.  M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.

Authors:  Azizi Ray; Clinton E Canal; J Christopher Ehlen; Kenner C Rice; Kevin Sean Murnane
Journal:  Neurotoxicology       Date:  2019-06-01       Impact factor: 4.294

7.  Role of µ, κ, and δ opioid receptors in tibial inhibition of bladder overactivity in cats.

Authors:  Zhaocun Zhang; Richard C Slater; Matthew C Ferroni; Brian T Kadow; Timothy D Lyon; Bing Shen; Zhiying Xiao; Jicheng Wang; Audry Kang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  J Pharmacol Exp Ther       Date:  2015-09-09       Impact factor: 4.030

8.  Individual short-acting opioids and the risk of opioid-related adverse events in adolescents.

Authors:  Cecilia P Chung; Stephen Todd Callahan; William O Cooper; William D Dupont; Katherine T Murray; Andrew D Franklin; Kathi Hall; Judith A Dudley; Charles Michael Stein; Wayne A Ray
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-08-16       Impact factor: 2.890

Review 9.  Tramadol with or without paracetamol (acetaminophen) for cancer pain.

Authors:  Philip J Wiffen; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-05-16

10.  Effects of chronic tramadol administration on cognitive flexibility in mice.

Authors:  Elpidio Attoh-Mensah; Marianne Léger; Gilles Loggia; Thomas Fréret; Chantal Chavoix; Pascale Schumann-Bard
Journal:  Psychopharmacology (Berl)       Date:  2021-06-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.